158 related articles for article (PubMed ID: 34639214)
1. LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.
Xiao L; Zhang C; Li X; Jia C; Chen L; Yuan Y; Gao Q; Lu Z; Feng Y; Zhao R; Zhao X; Cheng S; Shu Z; Xu J; Duan W; Nie G; Hou Y
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639214
[TBL] [Abstract][Full Text] [Related]
2. Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma.
Xiao L; Jin H; Duan W; Hou Y
Life Sci; 2020 Jul; 253():117740. PubMed ID: 32376265
[TBL] [Abstract][Full Text] [Related]
3. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
[TBL] [Abstract][Full Text] [Related]
6. Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.
Song XF; Wang QH; Huo R
Pathol Oncol Res; 2019 Jan; 25(1):377-389. PubMed ID: 29138985
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
[TBL] [Abstract][Full Text] [Related]
8. ANXA2 remodels the microstructures of caco2 cells.
Xing R; He H; He Y; Feng Y; Zhang C; Wu H; Sun M; Yu X; Liu Y; Song X; Wang X; Chen Y; Hou Y
Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1848-54. PubMed ID: 23522334
[TBL] [Abstract][Full Text] [Related]
9. Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
Shimomura A; Takasaki A; Nomura R; Hayashi N; Senda T
Med Mol Morphol; 2013 Mar; 46(1):14-9. PubMed ID: 23325550
[TBL] [Abstract][Full Text] [Related]
10. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
11. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
[TBL] [Abstract][Full Text] [Related]
12. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).
Zirkel A; Lederer M; Stöhr N; Pazaitis N; Hüttelmaier S
Nucleic Acids Res; 2013 Jul; 41(13):6618-36. PubMed ID: 23677615
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-381 inhibits metastasis and epithelial-mesenchymal transition of glioblastoma cells through targeting LEF1.
Min RQ; Ma Q
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6825-6833. PubMed ID: 32633375
[TBL] [Abstract][Full Text] [Related]
15. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
[TBL] [Abstract][Full Text] [Related]
16. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression.
Zhang Z; Kim K; Li X; Moreno M; Sharp T; Goodheart MJ; Safe S; Dupuy AJ; Amendt BA
Mol Cancer Ther; 2014 Jul; 13(7):1942-51. PubMed ID: 24785257
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
[TBL] [Abstract][Full Text] [Related]
19. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
[TBL] [Abstract][Full Text] [Related]
20. LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy.
Congrains-Castillo A; Niemann FS; Santos Duarte AS; Olalla-Saad ST
J Cell Mol Med; 2019 Apr; 23(4):3021-3025. PubMed ID: 30770626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
